Nektar Therapeutics announces 1-for-15 reverse stock split effective June 8

NEKTAR THERAPEUTICS

Board approved 1-for-15 reverse stock split effective June 8, 2025 at 11:59 p.m. ET.
Stockholders authorized reverse split ratio up to 1:40 at May 23 annual meeting; Board selected 1:15.
Split-adjusted trading begins June 9 under symbol NKTR with new CUSIP 640268306.
No fractional shares issued; rounding up for DTC participants, down for stock awards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.